Rachel Choi

Yale University

Papers

1

Total Citations

45

H-Index

1

About

Dr. Rachel Choi is a leading head and neck surgeon whose research has reshaped the surgical management of oropharyngeal cancer, particularly through the clinical adoption of transoral robotic surgery (TORS). Her landmark study, "Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption" (2018, 45 citations), provides a pivotal, population-level analysis comparing long-term oncologic outcomes and adjuvant therapy use among patients treated with TORS, nonrobotic surgery, and transoral laser microsurgery. By leveraging the National Cancer Database, Dr. Choi’s work demonstrated that TORS offers comparable oncologic outcomes while potentially reducing the need for adjuvant therapies, establishing a critical evidence base for its integration into standard practice. Her research directly informs surgical decision-making and patient counseling, bridging the gap between technological innovation and real-world clinical efficacy. Dr. Choi’s contributions are essential reading for surgeons and oncologists navigating the evolving landscape of minimally invasive head and neck cancer treatment, and her work continues to influence national guidelines and surgical training.

Research Focus

Key Achievements

1
H-Index
1
Papers
45
Total Citations
45
Avg Citations/Paper
🏆 Most Cited Paper
Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption
45 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Yale University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago